Early Renal Hyperfunction and Hypertrophy in IDDM Patients Including Comments on Early Intervention

  • Margrethe Mau Pedersen

Abstract

Diabetic nephropathy is the main cause of reduced survival in insulin-dependent diabetes. Much interest is paid to early alterations in kidney function and structure, since a relationship may exist between such early abnormalities and later development of diabetic nephropathy. A modest increase in urinary albumin excretion, microalbuminuria, has been identified as an early marker of diabetic nephropathy, and therapeutical intervention postponing the onset of overt nephropathy has been introduced. In this chapter the initial renal changes in IDDM, glomerular hyperfunction and renal hypertrophy, will be addressed.

Keywords

Glomerular Filtration Rate Diabetic Nephropathy Atrial Natriuretic Peptide Aldose Reductase Renal Plasma Flow 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mogensen CE. Glomerular hyperfiltration in human diabetes. Diabetes Care 1994; 17:770–775.PubMedGoogle Scholar
  2. 2.
    Bank N. Mechanisms of diabetic hyperfikration. Nephrology Forum. Kidney Int 1991; 40: 792–807.PubMedCrossRefGoogle Scholar
  3. 3.
    Mogensen CE. Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 1971; 28: 91–100.PubMedCrossRefGoogle Scholar
  4. 4.
    Ditzel J, Schwartz M. Abnormally increased glomerular filtration rate in shorWerm insulin-treated diabetic subjects. Diabetes 1976; 16:264–267.Google Scholar
  5. 5.
    Christenseti JS, Gammelgaard J, Frandsen M, Parving H-H. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia 1981;20:451–456.Google Scholar
  6. 6.
    Brøchner-Mortensen J, Ditzel J. Glomerular filtration rate and extracellular fluid volume in insulin-dependent patients with diabetes mellitus. Kidney Int 1982; 21:696–698.PubMedCrossRefGoogle Scholar
  7. 7.
    Hansen KW, Mau Pedersen M, Christensen CK, Schmitz A, Christiansen JS, Mogensen CE. Normoalbuminuna ensures no reduction of renal function in type 1 (insulin-dependent) diabetic patients. J Intern Med 1992; 232: 161–167.PubMedCrossRefGoogle Scholar
  8. 8.
    Mogensen CE. Kidney function and glomerular permeability to macromolecules in juvenile diabetes. Dan Med Bull 1972; 19: 1–36.PubMedGoogle Scholar
  9. 9.
    Christiansen JS, Gammelgaard J, Tronier B, Svendsen PA, Parving H-H. Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 1982; 21: 683–688.PubMedCrossRefGoogle Scholar
  10. 10.
    Nyberg G, Granerus G, Aurell M. Renal extraction ratios for 51Cr-EDTA, PAH, and glucose in early insulin-dependent diabetic patients. Kidney Int 1982; 21: 706–708.PubMedCrossRefGoogle Scholar
  11. 11.
    Christensen CK, Mogensen CE. The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabetic Med 1985; 2:97–102.PubMedCrossRefGoogle Scholar
  12. 12.
    Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89–93.PubMedCrossRefGoogle Scholar
  13. 13.
    Ellis EN, Steffes MW, Coetz FC, Sutherland DER, Mauer SM. Glomerular filtration surface in type 1 diabetes mellitus. Kidney Int 1986; 29: 889–894.PubMedCrossRefGoogle Scholar
  14. 14.
    Christiansen JS, Frandsen M, Parving H-H. The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 1981; 20: 199–204.PubMedGoogle Scholar
  15. 15.
    Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in early juvenile diabetes. Diabetes 1973; 22: 706–713.PubMedGoogle Scholar
  16. 16.
    Mogensen CE, Andersen MJF. Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalization by insulin-treatment. Diabetologia 1975; 11: 221–224.PubMedCrossRefGoogle Scholar
  17. 17.
    Puig JG, Anton FM, Grande C, Pallardo LF, Arnalich F, Gil A, Vazquez JJ, Garcia AM. Relation on kidney size to kidney function in early insulin-dependent diabetes. Diabetologia 1981;21:363–367.CrossRefGoogle Scholar
  18. 18.
    Schwieger J, Fine LG. Renal hypertrophy, growth factors, and nephropathy in diabetes mellitus. Semin Nephrol 1990; 10: 242–253.PubMedGoogle Scholar
  19. 19.
    Feldt-Rasmussen B, Hegedüs L, Mathiesen ER, Deckert T. Kidney volume in type 1 (insulin-dependent) diabetic patients with normal or increased urinary albumin excretion: effect of long-term improved metabolic control. Scand J Lab Invest 1991; 51: 31–36.Google Scholar
  20. 20.
    Østerby R, Gundersen HJG. Glomerular size and structure in diabetes mellitus: I. Early abnormalities. Diabetologia 1975; 11: 225–229.PubMedCrossRefGoogle Scholar
  21. 21.
    Seyer-Hansen K, Hansen J, Gundersen HJG. Renal hypertrophy in experimental diabetes: a morphometric study. Diabetologia 1980; 18: 501–505.PubMedCrossRefGoogle Scholar
  22. 22.
    Mathiesen ER, Hilsted J, Feldt-Rasmussen B, Bonde-Petersen F, Christensen NJ, Parving H-H. The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients. Diabetes 1985; 34: 1301–1305.PubMedCrossRefGoogle Scholar
  23. 23.
    Wolpert HA, Kinsley BT, Clermont AC, Wald H, Bursell S-E. Hyperglycemia modulates retinal hemodynamics in IDDM. Diabetes 1993; 42: A489.Google Scholar
  24. 24.
    Gray SD. Effect of hypertonicity on vascular dimensions in skeletal muscle. Microvasc Res 1971;3:117–124.PubMedCrossRefGoogle Scholar
  25. 25.
    Bank N. Mechanisms of diabetic hyperfiltration. Kidney Int 1991; 40: 792–807.PubMedCrossRefGoogle Scholar
  26. 26.
    Harvey JN, Edmundson AW, Jaffa AA, Martin LL, Mayfield RK. Renal excretion of kallikrein and eicosanoids in patients with Type 1 (insulin-dependent) diabetes mellitus. Relationship to glomerular and tubular function. Diabetologia 1992; 35: 857–862.PubMedCrossRefGoogle Scholar
  27. 27.
    Perico N, Benigni A, Gabanelli M, Piccinelli A, Rog M, De-Riva C, Remuzzi G. Atrial natriuretide peptide and prostacyclin synergistically mediate hvperfiltration and hypoperfusion of diabetic rats. Diabetes 1992; 41: 533–538.PubMedCrossRefGoogle Scholar
  28. 28.
    Blantz RC, Peterson OW, Gushwa L, Tucker BJ. Effect of modest hyperglycaemia on tubuloglomerular feedback activity. Kidney Int 1982; 22: S206–S212.Google Scholar
  29. 29.
    Christiansen JS, Christensen CK, Hermansen K, Pedersen EB, Mogensen CE. Enhancement of glomerular filtration rate and renal plasma flow by oral glucose load in well controlled insulin-dependent diabetics. Scand J Clin Lab Invest 1986; 46: 265–272.CrossRefGoogle Scholar
  30. 30.
    Christiansen JS, Frandsen M, Parving H-H. Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics. Diabetologia 1981; 21: 368–373.PubMedCrossRefGoogle Scholar
  31. 31.
    Wiseman MJ, Mangili R, Alberetto M, Keen H, Viberti GC. Glomerular response mechanisms to glycémie changes in insulin-dependent diabetics. Kidney Int 1987; 31:1012–1018.PubMedCrossRefGoogle Scholar
  32. 32.
    Mogensen CE. Glomerular filtration rate and renal plasma flow in normal and diabetic man during elevation of blood sugar levels. Scand J Clin Lab Invest 1971; 28: 177–182.PubMedCrossRefGoogle Scholar
  33. 33.
    Marre M, Dubin T, Hallab M, Beirut G, Bouhanick B, Lejeune J-J, Fressinaud P. Different renal response to hyperglycaemia in insulin-dependent diabetics at risk for, or protected against diabetic nephropathy. Diabetes 1993; 42: A423.Google Scholar
  34. 34.
    Skøtt P, Vaag A, Hother-Nielsen O, Andersen P, Bruun NE, Giese J, Beck-Nielsen H, Parving H-H. Effects of hyperglycaemia on kidney function, atrial natriuretic factor and plasma renin in patients with insulin-dependent diabetes mellitus. Scand J Clin Lab Invest 1991; 51:715–727.PubMedCrossRefGoogle Scholar
  35. 35.
    Mathiesen ER, Gall M-A, Hommel E, Skøtt P, Parving H-H. Effects of short-term strict metabolic control on kidney function and extracellular fluid volume in incipient diabetic nephropathy. Diabetic Med 1989; 6: 595–600.PubMedCrossRefGoogle Scholar
  36. 36.
    Christensen CK, Christiansen JS, Schmitz A, Christensen T, Hermansen K, Mogensen CE. Effect of continuous subcutaneous insulin infusion on kidney function and size in IDDM patients — a two years controlled study. J Diabetes and Its Complications 1987; 1: 91–95.CrossRefGoogle Scholar
  37. 37.
    Mogensen CE, Christensen CK, Mau Pedersen M, Alberti KGMM, Boye N, Christensen T, Christiansen JS, Flyvbjerg A, Ingerslev J, Schmitz A, Ørskov H. Renal and glycemic determinants of glomerular hyperfiltration in normoalbuminuric diabetics. J Diabetic Compl 1990; 4: 159–165.CrossRefGoogle Scholar
  38. 38.
    Mau Pedersen M, Christiansen JS, Pedersen EB, Mogensen CE. Determinants of intra-individual variation in kidney function in normoalbuminuric insulin-dependent diabetic patients: importance of atrial natriuretic peptide and glycemic control. Clin Sci 1992; 83: 445–451.Google Scholar
  39. 39.
    Greene DA, Lattimer SA, Sima AAF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987; 316: 599–606.PubMedCrossRefGoogle Scholar
  40. 40.
    Mau Pedersen M, Christiansen JS, Mogensen CE. Reduction of glomerular hyperfiltration in normoalbuminuric IDDM patients by 6 mo of aldose reductase inhibition. Diabetes 1991; 40: 527–531.CrossRefGoogle Scholar
  41. 41.
    Mau Pedersen M, Mogensen CE, Christiansen JS. Reduction of glomerular hyperfunction during short-term aldose reductase inhibition in normoalbuminuric, insulin-dependent diabetic patients. Endocrinol Metab 1995; 2: 55–62.Google Scholar
  42. 42.
    Passariello N, Sepe J, Marrazzo G, De Cicco A, Peluso A, Pisano MCA, Sgambato S, Tesauro P, D’Onofrio F. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate in IDDM subjects with nephropathy. Diabetes Care 1993; 16:789–795.PubMedCrossRefGoogle Scholar
  43. 43.
    Trevisan R, Nosadini R, Fioretto P, Avogaro A, Duner E, Iori E, Valerio A, Doria A, Crepaldi G. Ketone bodies increase glomerular filtration rate in normal man and in patients with type 1 (insulin dependent) diabetes. Diabetologia 1987; 30: 214–221.PubMedCrossRefGoogle Scholar
  44. 44.
    Gwinup G, Elias AN. Hypothesis. Insulin is responsible for the vascular complications of diabetes. Med Hypotheses 1991; 34:1–6.PubMedCrossRefGoogle Scholar
  45. 45.
    Qiristiansen JS, Frandsen M, Parving H-H. The effect of intravenous insulin infusion on kidney function in insulin-dependent diabetes mellitus. Diabetologia 1981; 20: 199–204.Google Scholar
  46. 46.
    Skøtt P, Hother-Nielsen O, Bruun NE, Giese J, Nielsen MD, Beck-Nielsen H, Parving H-H. Effects of insulin on kidney function and sodium excretion in healthy subjects. Diabetologia 1989; 32:694–699.PubMedCrossRefGoogle Scholar
  47. 47.
    Ortola FV, Ballermann BJ, Anderson S, Mendez RE, Brenner BM Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration. J Clin Invest 1987; 80: 670–674.PubMedCrossRefGoogle Scholar
  48. 48.
    Kikkawa R, Haneda M, Sakamoto K, Koya D, Shikano T, Nakanishi S, Matsuda Y, Shigeta Y. Antagonist for atrial natriuretic peptide receptors ameliorates glomerular hyperfittration in diabetic rats. Biochem Biophys Res Commun 1993; 193: 700–705.PubMedCrossRefGoogle Scholar
  49. 49.
    Qinstiansen JS, Gammelgaard J, Frandsen M, Ørskov H, Parving H-H. Kidney function and size in normal subjects before and during growth hormone administration for one week. Eur J Clin Invest 1981; 11: 487–490.CrossRefGoogle Scholar
  50. 50.
    Parving H-H, Christiansen JS, Noer I, Tronier B, Mogensen CE. The effect of glucagon infusion on kidney function in short-term insulin-dependent juvenile diabetics. Diabetologia 1980; 19: 350–354.PubMedCrossRefGoogle Scholar
  51. 51.
    Hoogenberg K, Dullaart RPF, Freling NJM, Meijer S, Sluiter WJ. Contributory roles of circulatory glucagon and growth hormone to increased renal haemodynamics in type 1 (insulin-dependent) diabetes mellitus. Scand J Clin Lab Invest 1993; 53: 821–828.PubMedCrossRefGoogle Scholar
  52. 52.
    Flyvbjerg A. »The role of insulin-like growth factor I in initial renal hypertrophy in experimental diabetes.« In Growth Hormone and Insulin-Like Growth Factor I. Flyvbjerg A, Ørskov H, Alberti KGMM, eds. John Wiley & Sons Ltd., 1993; pp 271–306.Google Scholar
  53. 53.
    Castellino P, Hunt W, DeFronzo RA Regulation of renal hemodynamics by plasma amino acid and hormone concentrations. Kidney Int 1987; 32: S-15–S-20.CrossRefGoogle Scholar
  54. 54.
    Mau Pedersen M, Mogensen CE, Schönau Jørgensen F, Møller B, Lykke G, Pedersen O. Renal effects from limitation of high dietary protein in normoalbuminuric diabetic patients. Kidney Int 1989;36:S-115–S-121.Google Scholar
  55. 55.
    Mau Pedersen M, Winther E, Mogensen CE. Reducing protein in the diabetic diet. Diabete Metab (Paris) 1990; 16: 454–459.Google Scholar
  56. 56.
    Jones MG, Lee K, Swaminathan R. The effect of dietary protein on glomerular filtration rate in normal subjects. Clin Nephrol 1987; 27: 71–75.PubMedGoogle Scholar
  57. 57.
    Pecis M, de Azevedo MJ, Gross JL. Chicken and fish diet reduces glomerular hyperfiltration in IDDM patients. Diabetes Care 1994; 17: 665–672.PubMedCrossRefGoogle Scholar
  58. 58.
    Kraus ES, Cheng L, Sikorski I, Spector DA. Effects of phosphorus restriction on renal response to oral and intravenous protein loads in rats. Am J Physiol 1993; 264: F752–F759.Google Scholar
  59. 59.
    Tuttle KR, Bruto JL, Perusek MC, Lancaster JL, Kopp DT, DeFronzo RA Effect of strict glycemic control on renal hemodynamic response to amino acids and renal enlargement in insulin-dependent diabetes mellitus. N Engl J Med 1991; 324: 1626–1632.PubMedCrossRefGoogle Scholar
  60. 60.
    Wisemann MJ, Saunders AJ, Keen H, Viberti GC. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 1985; 312:617–621.CrossRefGoogle Scholar
  61. 61.
    Shechter P, Boner G, Rabkin R. Tubular cell protein degradation in early diabetic renal hypertrophy. J Am Soc Nephrol 1994; 4: 1582–1587.PubMedGoogle Scholar
  62. 62.
    Schaefer L, Schaefer RM, Ling, Teschner M, Heidland A. Renal proteinases and kidney hypertrophy in experimental diabetes. Diabetologia 1994; 37: 567–571.PubMedCrossRefGoogle Scholar
  63. 63.
    Shankland SJ, Scholey JW, Ly H, Thai K. Expression of transforming growth factor-ßl during diabetic renal hypertrophy. Kidney Int 1994; 46: 430–442.PubMedCrossRefGoogle Scholar
  64. 64.
    Wang YX, Brooks DP. The role of adenosine in glycine-induced glomerular hyperfiltration in rats. J Pharmacol Exp Ther 1992; 263: 1188–1194.PubMedGoogle Scholar
  65. 65.
    Angielski S, Redlak M, Szczepanska KM. Intrarenal adenosine prevents hyperfiltration induced by atrial natriuretic factor. Miner Electrolyte Metab 1990; 16: 57–60.PubMedGoogle Scholar
  66. 66.
    Wang YX, Gellai M, Brooks DP. Dopamine DAI Receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats. Am J Physiol 1992; 262: F1055–F1060.Google Scholar
  67. 67.
    Jaffa AA, Vio CP, Silva RH, Vavrek RJ, Stewart JM, Rust PF, Mayfield RK. Evidence for renal kinins as mediators of amino acid-induced hyperfusion and hyperfiltration in the rat. J Clin Invest 1992; 89:1460–1468.PubMedCrossRefGoogle Scholar
  68. 68.
    Friedlander G, Blanchet BF, Nitenberg A, Laborie C, Assan R, Amiel C. Glucagon secretion is essential for aminoacid-induced hyperfiltration in man. Nephrol Dial Transplant 1990; 5: 110–117.PubMedCrossRefGoogle Scholar
  69. 69.
    Wahren J, Johansson B-L, Wallberg-Henriksson H. Does C-peptide have a physiological role? Diabetologia 1994; 37: Suppl. 2: S99–S107.CrossRefGoogle Scholar
  70. 70.
    Bouhanick B, Suraniti S, Berrut G, Bled F, Simard G, Lejeune JJ, Fressinaud P, Marre M. Relationship between fat intake and glomerular filtration rate in normotensive insulin-dependent diabetic patients. Diabete Metab (Paris) 1995; 21: 168–172.Google Scholar
  71. 71.
    Hostetter TH. Diabetic nephropathy. Metabolic versus hemodynamic considerations. Diabetes Care 1992; 15: 1205–1215.PubMedCrossRefGoogle Scholar
  72. 72.
    Mogensen CE. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 1986; 46: 201–206.PubMedCrossRefGoogle Scholar
  73. 73.
    Rudberg S, Persson B, Dalqvist G. Increased glomerular filtration rate predicts diabetic nephropathy-results form an 8 year prospective study. Kidney Int 1992; 41: 822–828.PubMedCrossRefGoogle Scholar
  74. 74.
    Chirelli F, Verrotti A, Morgese G. Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children. Pediatr Nephrol 1995; 9:154–158.CrossRefGoogle Scholar
  75. 75.
    Lervang H-H, Jensen S, Brøchner-Mortensen J, Ditzel J. Does increased glomerular filtration rate or disturbed tubular function early in the course of childhood type 1 diabetes predict the development of nephropathy? Diabetic Med 1992; 9:635–640.PubMedCrossRefGoogle Scholar
  76. 76.
    Yip WJ, Jones LS, Wiseman JM, Hill C, Viberti GC. Glomerular hyperfiltration in the prediction of nephropahty in IDDM. Diabetes vol. 45, dec. 1996; 1729–1733.PubMedCrossRefGoogle Scholar
  77. 77.
    Anderson S. Renal effects of converting enzyme inhibitors in hypertension and diabetes. J Cardiovasc Pharmacol 1990; 15: Suppl. 3: S11–S15.CrossRefGoogle Scholar
  78. 78.
    Mau Pedersen M, Christensen CK, Hansen KW, Christiansen JS, Mogensen CE. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment. Clin Invest Med 1991; 14:642–651.Google Scholar
  79. 79.
    Bakris GL, Slataper R, Vicknair N, Sadler R. ACE inhibitor mediated reductions in renal size and microalbuminuria in normotensive, diabetic subjects. J Diabetic Compl 1994; 8: 2–6.CrossRefGoogle Scholar
  80. 80.
    Mau Pedersen M, Christensen SE, Christiansen JS, Pedersen EB, Mogensen CE, Ørskov H. Acute effects of a somatostatin analogue on kidney function in type i diabetic patients. Diabetic Med 1990; 7:304–309.CrossRefGoogle Scholar
  81. 81.
    Serri O, Beauregard H, Brazeau P, Abribat T, Lamber J, Harris A, Vachon L. Somatostatin analogue, octreotide, reduces increased glomerular filtration rate and kidney size in insulin-dependent diabetes. JAMA 1991; 265; 888–892.PubMedCrossRefGoogle Scholar
  82. 82.
    Jacobs ML, Derkx FH, Stijnen T, Lamberts SW, Weber RF. Effect of long-acting somatostatin analog (Somatolin) on renal hyperfiltration in patients with IDDM. Diabetes Care 1997; 20 (4): 632–636.PubMedCrossRefGoogle Scholar
  83. 83.
    Mau Pedersen M, Schmitz A, Pedersen EB, Danielsen H, Christiansen JS. Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabetic Med 1988; 5: 562–569.CrossRefGoogle Scholar
  84. 84.
    Pecis M, Azevedo JM, Gross LJ. Glomerular Hyperfiltration is associated with blood pressure abnormalities in normotensive normoalbuminuric IDDM patients. Diabetes Care, vol. 20, no. 8, 1997; 1329–1333.PubMedCrossRefGoogle Scholar
  85. 85.
    Ichikawa I, Harris RC. Angiotensin actions in the kidney: Renewed insight into the old hormone (Editorial Review). Kidney Int 1991; 40: 583–596.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • Margrethe Mau Pedersen
    • 1
  1. 1.Medical Department MAarhus KommunehospitalAarhusDenmark

Personalised recommendations